{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:37Z","timestamp":1772166337832,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-024-03155-2","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T04:01:38Z","timestamp":1734667298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Appropriate use of vancomycin in a cardiac surgical unit"],"prefix":"10.1186","volume":"19","author":[{"given":"Sanaa","family":"Mekdad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leenah","family":"Alsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzan","family":"Alkhalaif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"3155_CR1","doi-asserted-by":"crossref","unstructured":"Sivaradjy M, Gunalan A, Priyadarshi K, Madigubba H, Rajshekar D, Sastry AS. (2021). Increasing trend of vancomycin-resistant enterococci bacteremia in a tertiary care hospital of South India: a three-year prospective study. Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine, 25(8), 881.","DOI":"10.5005\/jp-journals-10071-23916"},{"key":"3155_CR2","doi-asserted-by":"crossref","unstructured":"Boneca IG, Chiosis G. (2003). Vancomycinresistance: occurrence, mechanisms and strategies to combat it. Expert opinion on therapeutic targets, 7(3), 311\u201328.","DOI":"10.1517\/14728222.7.3.311"},{"issue":"5","key":"3155_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4103\/0972-5229.182197","volume":"20","author":"Q Abbas","year":"2016","unstructured":"Abbas Q, Haq AU, Kumar R, Ali SA, Hussain K, Shakoor S. Evaluation of antibiotic use in pediatric intensive care unit of a developing country. Indian J Crit care Medicine: peer-reviewed Official Publication Indian Soc Crit Care Med. 2016;20(5):291.","journal-title":"Indian J Crit care Medicine: peer-reviewed Official Publication Indian Soc Crit Care Med"},{"key":"3155_CR4","unstructured":"Acta Anaesthesiologica Scandinavica, 64(9), 1295\u20131304."},{"key":"3155_CR5","unstructured":"IDSA Home (idsociety.org)."},{"issue":"1","key":"3155_CR6","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1080\/22221751.2020.1769500","volume":"9","author":"O Ayobami","year":"2020","unstructured":"Ayobami O, Willrich N, Reuss A, Eckmanns T, Markwart R. The ongoing challenge of Vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections. Emerg Microbes Infections. 2020;9(1):1180\u201393.","journal-title":"Emerg Microbes Infections"},{"key":"3155_CR7","first-page":"214","volume":"20","author":"S Mandal","year":"2024","unstructured":"Mandal S, Kundu A, Borah D, Ray MS, Mondal C. Methicillin Resistant Staphylococcus aureus (MRSA) an underestimate threat. Airborne biocontaminants and their impact on Human Health. Aug. 2024;20:214\u201357.","journal-title":"Aug"},{"issue":"1","key":"3155_CR8","first-page":"1","volume":"16","author":"S Selim","year":"2022","unstructured":"Selim S. Mechanisms of grampositive Vancomycin resistance. Biomedical Rep. 2022;16(1):1\u20136.","journal-title":"Biomedical Rep"},{"issue":"4","key":"3155_CR9","first-page":"953","volume":"35","author":"S Joshi","year":"2021","unstructured":"Joshi S, Shallal A, Zervos M. Vancomycin-resistant enterococci: epidemiology, infection prevention, and control. Infect Disease Clin. 2021;35(4):953\u201368.","journal-title":"Infect Disease Clin"},{"issue":"10","key":"3155_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjqs-2018-008926","volume":"29","author":"GM Schrank","year":"2020","unstructured":"Schrank GM, Snyder GM, Davis RB, Branch-Elliman W, Wright SB. The discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococcus: impact upon patient adverse events and hospital operations. BMJ Qual Saf. 2020;29(10):1\u20132.","journal-title":"BMJ Qual Saf"},{"issue":"1","key":"3155_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/microorganisms11010024","volume":"11","author":"G Li","year":"2022","unstructured":"Li G, Walker MJ, De Oliveira DM. Vancomycin resistance in Enterococcus and Staphylococcus aureus. Microorganisms. 2022;11(1):24.","journal-title":"Microorganisms"},{"issue":"11","key":"3155_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA. Therapeutic monitoring of Vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious diseases pharmacists. Am J Health-System Pharm. 2020;77(11):835\u201364.","journal-title":"Am J Health-System Pharm"},{"issue":"5","key":"3155_CR13","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s11096-021-01266-7","volume":"43","author":"T Van Der Heggen","year":"2021","unstructured":"Van Der Heggen T, Buyle FM, Claus B, Somers A, Schelstraete P, De Paepe P, Vanhaesebrouck S, De Cock PA. Vancomycin dosing and therapeutic drug monitoring practices: guidelines versus real-life. Int J Clin Pharm. 2021;43(5):1394\u2013403.","journal-title":"Int J Clin Pharm"},{"issue":"01","key":"3155_CR14","doi-asserted-by":"publisher","first-page":"089","DOI":"10.4103\/JLP.JLP_32_17","volume":"10","author":"R Amberpet","year":"2018","unstructured":"Amberpet R, Sistla S, Parija SC, Rameshkumar R. Risk factors for intestinal colonization with Vancomycin resistant enterococci\u2019A prospective study in a level III pediatric intensive care unit. J Lab Physicians. 2018;10(01):089\u201394.","journal-title":"J Lab Physicians"},{"issue":"8","key":"3155_CR15","doi-asserted-by":"publisher","first-page":"881","DOI":"10.5005\/jp-journals-10071-23916","volume":"25","author":"M Sivaradjy","year":"2021","unstructured":"Sivaradjy M, Gunalan A, Priyadarshi K, Madigubba H, Rajshekar D, Sastry AS. Increasing trend of Vancomycin-resistant enterococci bacteremia in a tertiary care hospital of South India: a three-year prospective study. Indian J Crit Care Medicine: Peer-reviewed Official Publication Indian Soc Crit Care Med. 2021;25(8):881.","journal-title":"Indian J Crit Care Medicine: Peer-reviewed Official Publication Indian Soc Crit Care Med"},{"issue":"1","key":"3155_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12879-020-05005-7","volume":"20","author":"HS \u00d6zger","year":"2020","unstructured":"\u00d6zger HS, Fak\u0131o\u011flu DM, Erbay K, Albayrak A, H\u0131zel K. Inapropriate use of antibiotics effective against gram positive microorganisms despite restrictive antibiotic policies in ICUs: a prospective observational study. BMC Infect Dis. 2020;20(1):289.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"3155_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/mdr.2021.0109","volume":"28","author":"V Scaglione","year":"2022","unstructured":"Scaglione V, Reale M, Davoli C, Mazzitelli M, Serapide F, Lionello R, La Gamba V, Fusco P, Bruni A, Procopio D, Garofalo E. Prevalence of antibiotic resistance over time in a third-level university hospital. Microb Drug Resist. 2022;28(4):425\u201335.","journal-title":"Microb Drug Resist"},{"issue":"9","key":"3155_CR18","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1128\/AAC.00925-16","volume":"60","author":"JP Burnham","year":"2016","unstructured":"Burnham JP, Burnham CA, Warren DK, Kollef MH. Impact of time to appropriate therapy on mortality in patients with Vancomycin-intermediate Staphylococcus aureus infection. Antimicrob Agents Chemother. 2016;60(9):5546\u201353.","journal-title":"Antimicrob Agents Chemother"},{"key":"3155_CR19","unstructured":"Kim NakHyun KN, Koo HeiLim KH, Choe PyeongGyun CP, Cheon ShinHye CS, Kim MoonSuk KM, Lee MyungJin LM. Jung YoungHee JY, Park WanBeom PW, Song KyoungHo SK, Kim EuSuk KE, Bang JiHwan BJ. Inappropriate continued empirical Vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus."},{"issue":"6","key":"3155_CR20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.dld.2017.01.157","volume":"49","author":"V Zuccaro","year":"2017","unstructured":"Zuccaro V, Columpsi P, Sacchi P, Luc\u00e0 MG, Fagiuoli S, Bruno R. Antibiotic stewardship and empirical antibiotic treatment: how can they get along? Dig Liver Disease. 2017;49(6):579\u201384.","journal-title":"Dig Liver Disease"},{"key":"3155_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00134-019-05866-w","volume":"46","author":"A Tabah","year":"2020","unstructured":"Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, Roberts JA, Schouten J, Giamarellou H, Rello J, De Waele J. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious diseases (ESCMID) critically Ill patients Study Group (ESGCIP). Intensive Care Med. 2020;46:245\u201365.","journal-title":"Intensive Care Med"},{"issue":"5","key":"3155_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14787210.2022.2013809","volume":"20","author":"L Bottalico","year":"2022","unstructured":"Bottalico L, Charitos IA, Potenza MA, Montagnani M, Santacroce L. The war against bacteria, from the past to present and beyond. Expert Rev Anti-infective Therapy. 2022;20(5):681\u2013706.","journal-title":"Expert Rev Anti-infective Therapy"},{"key":"3155_CR23","doi-asserted-by":"crossref","unstructured":"Verma MK, Gayathri S, Ashokkumar B, Varalakshmi P. Trends in Antimicrobial Therapy: Current Approaches and Future Prospects. Biomolecular Engineering Solutions for Renewable Specialty Chemicals: Microorganisms, Products, and Processes. 2021 Oct 25:111\u2009\u2013\u200940.","DOI":"10.1002\/9781119771951.ch4"},{"key":"3155_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10096-007-0272-x","volume":"26","author":"J Gomez","year":"2007","unstructured":"Gomez J, Garcia-Vazquez E, Banos R, Canteras M, Ruiz J, Ba\u00f1os V, Herrero JA, Valdes M. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis. 2007;26:239\u201345.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"3155_CR25","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1097\/IPC.0000000000000944","volume":"29","author":"M YaddolahiFar","year":"2021","unstructured":"YaddolahiFar M, Sheybani F, Eslami S, Taherzadeh Z, Naderi H, Mohseni M, Zakeri E, Khosravi N. Why Vancomycin is overly prescribed despite the lack of supporting Microbiological data: to design a Concept Map. Infect Dis Clin Pract. 2021;29(2):e101\u20134.","journal-title":"Infect Dis Clin Pract"},{"issue":"2","key":"3155_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.34172\/ajpr.2021.11","volume":"2","author":"MA Ghollar","year":"2021","unstructured":"Ghollar MA, Rangchian M, Etminaniesfahani M. Retrospective drug utilization evaluation of Vancomycin usage in infectious wards and intensive care units in Hamedan teaching hospitals, April to September 2020. Avicenna J Pharm Res. 2021;2(2):55\u20139.","journal-title":"Avicenna J Pharm Res"},{"issue":"4","key":"3155_CR27","doi-asserted-by":"publisher","first-page":"e202899","DOI":"10.1001\/jamanetworkopen.2020.2899","volume":"3","author":"C Rhee","year":"2020","unstructured":"Rhee C, Kadri SS, Dekker JP, Danner RL, Chen HC, Fram D, Zhang F, Wang R, Klompas M, CDC Prevention Epicenters Program. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw open. 2020;3(4):e202899.","journal-title":"JAMA Netw open"},{"key":"3155_CR28","first-page":"29","volume":"8","author":"M Mahi-Birjand","year":"2019","unstructured":"Mahi-Birjand M, Ziaee M, Bijari B, Khalvati R, Abedini MR, Golboei Mousavi H, Ziaee A. Evaluation of Vancomycin use in university-affiliated hospitals in Southern Khorasan Province (East Iran) based on HICPAC guidelines. Drug, Healthcare and Patient Safety. Apr. 2019;8:29\u201335.","journal-title":"Apr"},{"key":"3155_CR29","unstructured":"Yuliandra Y. Targeting Bacterial Resistance: Rational Design and Evaluation of Antibiotic Combinations with Adjuvants (Doctoral dissertation)."},{"issue":"4","key":"3155_CR30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/FTD.0000000000001075","volume":"45","author":"AS Lim","year":"2023","unstructured":"Lim AS, Foo SH, Seng JJ, Ng TT, Chng HT, Han Z. Area-under-curve\u2013guided Versus Trough-guided monitoring of Vancomycin and its impact on nephrotoxicity: a systematic review and Meta-analysis. Ther Drug Monit. 2023;45(4):519\u201332.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"3155_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jiac.2017.09.010","volume":"24","author":"CJ Phillips","year":"2018","unstructured":"Phillips CJ, McKinnon RA, Woodman RJ, Gordon DL. Sustained improvement in Vancomycin dosing and monitoring post-implementation of guidelines: results of a three-year follow-up after a multifaceted intervention in an Australian teaching hospital. J Infect Chemother. 2018;24(2):103\u20139.","journal-title":"J Infect Chemother"},{"issue":"10","key":"3155_CR32","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Hamilton CW. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51\u201377.","journal-title":"Clin Infect Dis"},{"key":"3155_CR33","doi-asserted-by":"crossref","unstructured":"Alavi-Moghadam M, Shahim F, Sistanizad M, Pourheidar E, Hassanpour R. Vancomycin prescription pattern in a teaching hospital: the promising role of antimicrobial control programs. J Pharm Care. 2020 Jun;26:53\u20136.","DOI":"10.18502\/jpc.v8i2.3828"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-03155-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-024-03155-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-03155-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T04:04:23Z","timestamp":1734667463000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-024-03155-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3155"],"URL":"https:\/\/doi.org\/10.1186\/s13019-024-03155-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4374842\/v1","asserted-by":"object"}]},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"King Fahad Medical center (KFMC ) and all authors agree for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable\u2019 as the research was retrospective and all patient\u2019s name and identification had been removed under the supervision of KFM research center .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"669"}}